Big data takes on heart disease: can a toolbox of info boost statin use?

NCT ID NCT04067297

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 'toolbox' of educational materials—including report cards for doctors, patient handouts, and an online decision aid—can increase the use of cholesterol-lowering statins in communities with high rates of heart disease. Researchers will track prescription data from over 500,000 people in Ontario using big data. The goal is to see if this real-world approach helps prevent heart attacks and strokes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Lipid management toolbox (educational materials, report cards, decision aid, videos)
What this could lead to
If successful, this approach could show that using big data in real-world settings can improve cholesterol management and prevent heart attacks and strokes in high-risk communities.
What could go wrong
This is an observational-style trial testing a community-level intervention, not a new drug. The results may not apply to other regions or populations, and the toolbox may not change prescribing habits as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ICES

    Toronto, Ontario, M4N3M5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.